[ad_1]
class = “cf”>
Ugur Sahin, founder of the Biontech company, which developed the world’s first approved Kovid-19 vaccine, spoke to the German press.
Speaking to Der Spiegel magazine and Bild newspaper, Şahin said that with the vaccination, there will be a significant and permanent decrease in the number of cases in late May or early June. Şahin said: “The important criterion is that a sufficient number of people have been vaccinated up to that period. However, taking Kovid-19 under control does not mean that the virus will no longer be transmitted and will be completely over.
‘THE ELDERLY SHOULD BE ACCELERATED TO GET THE VACCINATION’
Saying that mutations rapidly increase the number of deaths, Uğur urahin said: “I am concerned about this situation. It seems that due to the new mutations, the vaccine against the Kovid-19 epidemic will gain new momentum without providing herd immunity, ”he stressed that the Biontech-Pfizer vaccine is effective against mutations.
‘DO NOT EXPECT THE VACCINE WILL BE SO EFFECTIVE’
class = “cf”>
Stating that the data obtained in Israel proves that their vaccines are effective against mutations, “We see the light at the end of the tunnel. Visible light is not tunnel light either. Thanks to the efficacy of the vaccine, both the transmission of the virus and the development of the virus in humans are prevented. “I did not expect the vaccine to be so effective,” he said.
‘LIKE THE FLU VACCINE, EVERY TWO YEARS YOU WILL NEED A VACCINE’
Stating that those with two doses of vaccine may need a third vaccine next year due to the Kovid-19 mutation, Şahin said: “It is important that we make the immunity in society permanent in the fight against the virus. most likely we will need to repeat the vaccine every two years against the mutations that may appear. It will also be true for -19. This will now be our new normal, “he said.
class = “cf”>
When asked about his views on the Kovid-19 situation in Germany, inahin said: “The decrease in the number of cases will be delayed because the mutated virus in England is effective in Germany”, saying: “It is understood “Mutations will create a problem. It is necessary to accelerate the vaccination of the elderly. This will help us reduce the number of victims by the end of March,” he said.
